University of Alabama-Birmingham Joins New HIV Vaccine Initiative – The Body
Posted by pozlife on June 10, 2008
June 9, 2008
The National Institute of Allergy and Infectious Diseases has selected 10 research teams to work on a novel HIV vaccine approach.
The goal of the $15.6 million, five-year project is to attempt to neutralize HIV by activating white blood cells called B cells. In the immune system, B cells recognize antigens, a type of microbe, and produce antibodies that can lock onto antigens and flush them from the body. However, HIV can evade these B cells. Stimulating B cell production of protective antibodies to neutralize multiple HIV strains is believed to be a promising approach in the quest for an HIV vaccine.
Research centers involved in the project include the University of Alabama-Birmingham (UAB); Scripps Research Institute in La Jolla, Calif.; Vanderbilt University in Nashville; University of California-Irvine; University of Florida; Weill Cornell Medical College in New York City; University of Medicine and Dentistry of New Jersey in Newark; Uniformed Services University of the Health Sciences in Bethesda, Md.; University of Rochester; and the University of Colorado-Denver.
Dr. Harry W. Schroeder Jr. in the Division of Clinical Immunology and Rheumatology was awarded a $275,000 grant to helm the research at UA